The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial interest in the reality and impact of inuse handling of protein medicines.

Engage with the influencers shaping European pharmaceutical law.

How do you choose the right path to bring your drug discovery to patients? Join this JLABS program to discover the pros and cons.

Join to discover the results of the ITCC-P4 public-private partnership.

With the EU HTA regulation now in force (January 2025), this session will explore the critical need to account for vaccines specificities in the implementation of the EU HTA regulation to optimise their access and impact on public health, economy and society across Europe and globally.

Register now to join this webinar.

The Lp(a) Global Summit 2025 is an exclusive, high-level event dedicated to shaping the future of cardiovascular health by focusing on Lipoprotein(a) [Lp(a)].

Join us on 19 March in Brussels to discuss how we can work together to accelerate progress to improve cancer care

Experience state of the art content in 100+ sessions, filled with conversations on today's healthcare priorities and latest developments in global collaboration, where regulatory reliance and harmonisation lead to streamlined decision making.

Women play a pivotal role across the life sciences sector. Amidst an era of exciting innovations, the legal and regulatory environment is evolving and women from firms and industry are at the forefront of navigating this terrain

An overview of the economic and health benefits of investing in the prevention, early detection and treatment of five major NCDs

Johnson & Johnson Innovation – JLABS invites you for a program that takes an in-depth look into essential aspects of a CTA such as preclinical development, clinical trial design, regulatory strategy, drug metabolism pharmacokinetics, and chemistry, manufacturing & controls.

People who have diabetes are also more likely to develop certain complications, such as hypoglycaemia and diabetic kidney disease. IMI projects Beat-DKD and HypoResolve explored what sparks the onset of these complications and how best to manage and treat them.